Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-01-13

FDA Approved: LOREEV XR — Supplemental Application (Almatica Pharma LLC)

View source ↗

Summary

The FDA approved a supplemental application for LOREEV XR (lorazepam) submitted by Almatica Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOREEV XR (lorazepam)

Snippet

SUPPL AP for LOREEV XR (LORAZEPAM)